Online ISSN: 1947-6027
Mission
Genes & Cancer's mission is to combine research from the fields of genomics, bioinformatics, and modem genetics to determine how cancer cells overcome growth regulatory pathways. We aim to cover all aspects of oncogenes, growth suppressor and apoptotic genes, and their roles in tumor development.
Genes & Cancer (formerly a SAGE publication) was acquired in 2014. It is a traditional, peer-reviewed, bi-monthly journal with free access.

As a traditional journal, Genes & Cancer publishes papers online in issues with page numbers. Each issue/paper can be printed upon special request.

Advance papers are usually published online several days after acceptance. All Genes & Cancer content is archived in PubMed Central.

The publisher also maintains the journal's own digital archive.

ARCHIVING & INDEXING
  • PubMed
  • PubMed Central
  • Scopus/Q1 rank (the highest) - Cancer Research category
  • EMBASE
  • META (Chan Zuckerberg Initiative)
  • Dimensions (Digital Science)

The journal covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, as well as their role in signal transduction and the mechanisms by which their expression and function are altered during tumor development. Genes & Cancer aims to capture the excitement of new phases of cancer research through genomics, bioinformatics and modern genetics.

Genes & Cancer is indexed/abstracted in PubMed, PubMed Central, Scopus (Cancer Research category, Q1 rank), and EMBASE. In 2018, Genes & Cancer was invited to participate and is now indexed in META, a world-renowned database of scientific literature.

Genes & Cancer is now offering free Altmetric Article Reports as a new part of our Journal platform, which enables real-time tracking of article coverage in digital and traditional media channels, often long before traditional citations begin to accrue.

We are pleased to announce the new face of Genes & Cancer coming in 2019 with an enhanced content delivery platform, new features and intuitive navigation.

Genes & Cancer always follows the COPE guidelines and ICMJE's Recommendations

Genes & Cancer is a member of the Committee on Publication Ethics (COPE)

Join our Genes mailing list